Showing results (1401-1410 of 3,550) with videos related to

Sort By:
Pageof 355
Thoracic Cancer|October 20, 2022
A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinomaKai Xie, Chao Zheng, Wenfeng Gu, et al.
Thoracic Cancer|October 21, 2022
Intraoperative ultrasound: "Alternative eye" in lymph nodal dissection in non-small cell lung cancerGaetana Messina, Mary Bove, Antonio Noro, et al.
Thoracic Cancer|October 21, 2022
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitorWenxian Wang, Qian Wang, Chunwei Xu, et al.
Thoracic Cancer|October 24, 2022
Application of several machine learning algorithms for the prediction of afatinib treatment outcome in advanced-stage EGFR-mutated non-small-cell lung cancerTaeyun Kim, Sang Jin Lee, Tae-Won Jang
Thoracic Cancer|October 26, 2022
Impact of the combination of sintilimab and chemotherapy on the tumor and paratumor PD-L1, IDO, TIM-3, FOXP3+ and CD8 expressions in patients with advanced esophageal squamous cell carcinomaShifa Zhang, Haibo Cai, Junjun Huang, et al.
Thoracic Cancer|September 2, 2022
Lung-specific exosomes for co-delivery of CD47 blockade and cisplatin for the treatment of non-small cell lung cancerZhilei Cui, Zhengshang Ruan, Junxiang Zeng, et al.
Thoracic Cancer|September 2, 2022
Prognostic factors for long-term survival following complete resection by lobectomy in stage I non-small cell lung cancerChristian Galata, Antje Messerschmidt, Marko Kostic, et al.
Thoracic Cancer|September 4, 2022
Virtual navigation bronchoscopy-guided intraoperative indocyanine green localization in simultaneous surgery for multiple pulmonary nodulesQingjie Yang, Kaibao Han, Shenghua Lv, et al.
Thoracic Cancer|October 13, 2022
Is it necessary for patients with potentially resectable esophageal squamous cell cancer to receive routine preoperative brain MRI/CT?Xiufeng Wei, Peng Luo, Xiankai Chen, et al.
Thoracic Cancer|September 15, 2022
Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung diseaseKenji Otsuka, Hiroshi Nokihara, Atsushi Mitsuhashi, et al.
Pageof 355